USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023

Meducourse Verified independent store

→

USCAP Update On Hematopathology Classification: The International Consensus Classification Perspective 2023 USCAP Update On Hematopathology Classification: The International Consen sus Classification Perspective 2023 The diagnosis and classification of hematopoietic tumors is increasingly complex and evolves rapidly. The introduction of the International Consensus Classification (ICC) of Myeloid and Lymphoid Neoplasms and publication of the proposed 5th edition World Health Organization (WHO) classification of the same tumors is the latest stage in this evolution and both further expand the clinical, morphologic, immunophenotypic and molecular genetic criteria for diagnosis. Join USCAP and learn from developers of the ICC on what is new in the classification of these tumors and how the ICC and proposed WHO compare. Leading clinical experts in hematology/oncology will also provide clinician perspectives on the importance of proper disease classification. The course will include disease specific lectures as well as opportunities to join experts in interactive microscopy sessions to gain practical knowledge on how to implement the new disease classifications into practice. Videos+PDFs Original release date: November 17, 2023 Small B-cell Neoplasms – Rebecca King, MD Section: 1 Presentation 1 Document Lymphoplasmacytic Lymphoma, Myeloma and Related Neoplasms – James Cook, MD, PhD Section: 1 Presentation 1 Document Cutaneous Lymphomas – John Goodlad, MD, MBChB, FRCPath Section: 1 Presentation 1 Document Clinician Perspective on the Diagnosis of B-cell Lymphoma – Jane Winter, MD Section: 1 Presentation 1 Document Aggressive B-cell Lymphomas – Elias Campo, MD, PhD Section: 1 Presentation 1 Document Hodgkin Lymphoma and Grey Zone Lymphomas – Elias Campo, MD, PhD Section: 1 Presentation 1 Document T-cell Lymphoma – Leticia Quintanilla-Fend, MD Section: 2 Presentations 1 Document Molecular Approach to Malignant Lymphoma – Laurence de Leval, MD, PhD Section: 1 Presentation 1 Document Clinician Perspective on the Diagnosis of T-cell Neoplasms – Steve Horwitz, MD Section: 1 Presentation 1 Document Immunodeficiency-associated Lymphoproliferative Disorders – Elaine Jaffe, MD Section: 1 Presentation 1 Document Histiocytic and Dendritic Cell Neoplasms – Elaine Jaffe, MD Section: 1 Presentation 1 Document Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage – Michael Borowitz, MD, PhD Section: 1 Presentation 1 Document Clonal Hematopoiesis and Myelodysplastic Syndromes – Robert Hasserjian, MD Section: 1 Presentation 1 Document Myeloproliferative Neoplasms – Hans-Michael Kvasnicka, MD, PhD Section: 1 Presentation 1 Document Mastocytosis – Attilio Orazi, MD, FRCPath Section: 1 Presentation 1 Document Clinician Perspective on the Diagnosis of Eosinophilic and Mast Cell Disorders – Ayalew Tefferi, MD Section: 1 Presentation 1 Document Myeloid/lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions – Sa Wang, MD Section: 1 Presentation 1 Document Myelodysplastic/myeloproliferative Neoplasms – Attilio Orazi, MD, FRCPath Section: 1 Presentation 1 Document Pediatric and/or Germline Disorders – Katherine Calvo, MD, PhD Section: 1 Presentation 1 Document Acute Myeloid Leukemia – Daniel Arber, MD Section: 1 Presentation 1 Document Clinician Perspective on the Diagnosis of Acute Myeloid Leukemia – Olatoyosi Odenike, MD Section: 1 Presentation 1 Document Molecular Approach to Myeloid Disorders – Adam Bagg, MD Section: 1 Presentation 1 Document Show more